Original paper

Interleukin-1 receptor antagonist anakinra in association with remdesivir in severe COVID-19: A case report

Volume: 97, Pages: 215 - 218
Published: Aug 1, 2020
Abstract
We report the first successful treatment with the IL-1 receptor antagonist anakinra, in association with the most promising and available antiviral therapy, of a severe case of novel coronavirus disease 2019 (COVID-19). We describe the diagnosis, clinical course, and management of the case, including the respiratory failure at presentation, the progression to a scenario characterized by profound inflammatory dysregulation similar to that...
Paper Details
Title
Interleukin-1 receptor antagonist anakinra in association with remdesivir in severe COVID-19: A case report
Published Date
Aug 1, 2020
Volume
97
Pages
215 - 218
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.